Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
5
Teradata Corp
TDC
US OptionsDetailed Quotes
AKYA250516C2500
- 0.00
- 0.000.00%
15min DelayClose Apr 24 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV96.85%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma12.70Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Akoya Biosciences Newsroom
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Cuts Target Price to $1.65
Akoya Biosciences Analyst Ratings
Stephens Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Cuts Target Price to $1.8
Akoya Biosciences Cut to Equal-Weight From Overweight by Stephens & Co.
Akoya Biosciences Price Target Cut to $1.80/Share From $3.50 by Stephens & Co.
CCORF Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $3.5
CCORF Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $3.5
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Hold Rating
Akoya Biosciences (AKYA) Receives a Hold From Craig-Hallum
Akoya Biosciences Analyst Ratings
Buy Rating Affirmed for Quanterix Amid Strong Q4 Performance and Strategic Merger With Akoya Biosciences
Akoya Biosciences: Hold Rating Amid Revenue Decline and Merger Uncertainties
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $2.4
Piper Sandler Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Cuts Target Price to $2.4
BTIG Maintains Akoya Biosciences(AKYA.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA) and HCA Healthcare (HCA)
BTIG Maintains Akoya Biosciences(AKYA.US) With Hold Rating
Hold Rating Suggested Amid Acquisition Uncertainties and Growth Concerns for Akoya Biosciences
J.P. Morgan Maintains Akoya Biosciences(AKYA.US) With Hold Rating
CCORF Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Maintains Target Price $3.5
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
